Glaucoma implant study halted early – but shows promise for pressure control
NCT ID NCT04770324
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study tested a new implant (Supraflow) placed in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. The goal was to see if two implants could safely reduce eye pressure enough to replace or reduce the need for daily eye drops. The study was stopped early, but it included 22 adults aged 50 and older whose glaucoma medications were no longer working well enough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA OPEN-ANGLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Malayan Center
Yerevan, 0033, Armenia
Conditions
Explore the condition pages connected to this study.